OverviewSuggest Edit

Acacia Pharma is a hospital pharmaceutical company. It focuses on the development and commercialization of products aimed at improving the care of patients undergoing surgery, other invasive procedures, or cancer chemotherapy. It offers a range of products dedicated to the treatment and prophylaxis of postoperative nausea and vomiting as well as to the use during invasive medical procedures.
TypePublic
Founded2007
HQDuxford, GB
Websiteacaciapharma.com

Latest Updates

Employees (est.) (May 2021)72(+95%)
Share Price (Jun 2021)€2.2
Cybersecurity ratingAMore

Key People/Management at Acacia Pharma

Mike Bolinder

Mike Bolinder

Chief Executive Officer
Scott Byrd

Scott Byrd

Independent Chairman
Ed Borkowski

Ed Borkowski

Independent Non-Executive Director
Alessandro della Chà

Alessandro della Chà

Non-Executive Director
Show more

Acacia Pharma Office Locations

Acacia Pharma has offices in Duxford and Indianapolis
Duxford, GB (HQ)
Royston Rd
Indianapolis, IN, US
8440 Allison Pointe Blvd #100
Show all (2)

Acacia Pharma Financials and Metrics

Acacia Pharma Revenue

Market capitalization (11-Jun-2021)

214.4m

Closing stock price (11-Jun-2021)

2.2
Acacia Pharma's current market capitalization is €214.4 m.
Show all financial metrics

Acacia Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Acacia Pharma Online and Social Media Presence

Embed Graph

Acacia Pharma News and Updates

Acacia Pharma to Participate in Jefferies Virtual Healthcare Conference

Acacia Pharma to Participate in Jefferies Virtual Healthcare Conference

Acacia Pharma Appoints Debra Hussain as Chief Commercial Officer

THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION - THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital and Reduction in Debt Service Obligations

THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less

Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less

Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference

 Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference

Acacia Pharma wins BEL Small Company of the Year for the second consecutive year

 Acacia Pharma wins BEL Small Company of the Year for the second consecutive year
Show more

Acacia Pharma Blogs

Acacia Pharma Group plc: Notice of Annual General Meeting

Acacia Pharma Group plc: Notice of Annual General Meeting

Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital

Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital

Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists

Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists
Show more

Acacia Pharma Frequently Asked Questions

  • When was Acacia Pharma founded?

    Acacia Pharma was founded in 2007.

  • Who are Acacia Pharma key executives?

    Acacia Pharma's key executives are Mike Bolinder, Scott Byrd and Ed Borkowski.

  • How many employees does Acacia Pharma have?

    Acacia Pharma has 72 employees.

  • Who are Acacia Pharma competitors?

    Competitors of Acacia Pharma include Cadila Pharmaceuticals, Alembic Pharmaceuticals and EMS Pharma.

  • Where is Acacia Pharma headquarters?

    Acacia Pharma headquarters is located at Royston Rd, Duxford.

  • Where are Acacia Pharma offices?

    Acacia Pharma has offices in Duxford and Indianapolis.

  • How many offices does Acacia Pharma have?

    Acacia Pharma has 2 offices.